We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

REM:JSERemgro Limited Analysis

Data as of 2026-05-22 - not real-time

ZAC 19,041.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Remgro Ltd. is trading at ZAc 19,041, comfortably above its 20‑day (ZAc 19,075) and 50‑day (ZAc 19,022) simple moving averages, indicating a short‑term bullish bias. The RSI sits at 49, suggesting the stock is neither overbought nor oversold, while the MACD histogram is negative (-11.6) and the signal line is bearish, hinting at potential near‑term weakness. Volume has been decreasing, which may temper the bullish price action, but the low beta (0.12) and modest 30‑day volatility (15.2%) point to a relatively stable price profile. The PE ratio of 0.69 is dramatically below the industry average of 16.7, and analysts’ target price of ZAc 21,413 implies roughly a 12% upside, supporting an undervalued view. Dividend yield remains attractive at 2.22% with an exceptionally low payout ratio of 1.25%, underscoring strong dividend sustainability. The fear‑greed index sits at 90.93 (“Extreme Greed”), reflecting a market environment that is currently very optimistic on equities. Overall, Remgro’s solid balance sheet, modest revenue growth (2.8%), and diversified investment portfolio provide a resilient foundation despite mixed technical signals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish trend with price above key SMAs
  • Bearish MACD and decreasing volume
  • Support level at ZAc 18,296 providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued valuation metrics (PE 0.69 vs industry 16.7)
  • 12% upside to analyst target price
  • Sustainable dividend and low payout ratio

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Diversified investment portfolio across multiple sectors and regions
  • Low beta and modest volatility indicating defensive characteristics
  • Strong balance sheet with ample cash and manageable debt

Key Metrics & Analysis

Financial Health

Revenue Growth2.80%
Profit Margin9.21%
P/E Ratio0.7
ROE3.67%
ROA1.34%
Debt/Equity4.05
P/B Ratio0.9
Op. Cash FlowZAC9.7B
Free Cash FlowZAC739.6M
Industry P/E16.7

Technical Analysis

TrendBullish
RSI49.1
SupportZAC 18,296.00
ResistanceZAC 19,816.00
MA 20ZAC 19,075.95
MA 50ZAC 19,022.28
MA 200ZAC 18,007.52
MACDBearish
VolumeDecreasing
Fear & Greed Index90.93

Valuation

Fair ValueZAC 3,837.95
Target PriceZAC 21,413.50
Upside/Downside12.46%
GradeUndervalued
TypeValue
Dividend Yield2.22%

Risk Assessment

Beta0.12
Volatility15.20%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.